Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04596-z An early assessment of the UK’s Our Future Health project shows how national-scale cohorts may reshape population medicine by accelerating discovery and clinical recruitment, provided that selection and phenotyping biases are carefully measured and managed. Read More
Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04634-w The Value Cube: translating clinical benefit into realizable value in global oncology Read More
Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04631-z The transition from AI-assisted tools to more integrated, AI-native models of care requires workflow integration, clinician engagement and measurable clinical value. Read More
Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04602-4 An in-depth phenomic analysis of health and disease patterns from 1.9 million participants of the Our Future Health cohort reports the prevalence of health conditions and medication-use patterns compared with national UK estimates and the UK Biobank. Read More
Nature Medicine, Published online: 10 September 2026; doi:10.1038/s41591-026-04572-7 In a phase 1 trial evaluating intravenous delivery of a next-generation CD3×CD19 bispecific T cell engager in patients with active systemic lupus erythematosus, treatment was well tolerated, and there were improvements in disease activity scores for most patients. Read More